Submitted: 18 Aug 2021
Revision: 05 Sep 2021
Accepted: 11 Sep 2021
ePublished: 30 Sep 2021
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)

Int J Basic Sci Med. 2021;6: 111-116.
doi: 10.34172/ijbsm.2021.20
  Abstract View: 230
  PDF Download: 172

Original Article

Seroprevalence of SARS-COV-2 Antibodies in Medical Staff, South-West of Iran

Amir Emami 1* ORCID logo, Fatemeh Javanmardi 1, Neda Pirbonyeh 1, Sedigheh Moradi Ghermezi 1, Tahereh Rezaei 2, Hamid Bakhtiari 3, Ali Mansouri 2

1 Microbiology Department, Burn and Wound Healing Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
2 Vice Chancellor for Treatment, Shiraz University of Medical Sciences, Shiraz, Iran
3 Vice Chancellor for Health Affairs Center of Disease Control (CDC), Shiraz University of Medical Sciences, Shiraz, Iran
*Corresponding Author: Email: emami.microbia@gmail.com


Introduction: Serological assay has critical role in defining immunity based on seroprevalence. Identifying the extend of seropositivity would determine the truly infected cases. Method: We conducted serologic testing for SARS-COV-2 antibodies in 492 health care workers (HCWs) before vaccination program in Shiraz, Iran (30 April 2020). Results: Based on job position, cases were divided into two categories: frontline staff (169, 34.34%) and non-front-line staff (323, 65.65%). Of all cases 40.65 were female and the rest of them were male. Mean age was estimated 47.97 ± 109.20 and 38.98 ± 8.76 in high risk and low risk population respectively (P = 0.1). In total 367 (74.59%) subjects reported to suffered at least one of the COVID-19 symptoms. More than half of cases (73.57) had history of COVID-19 disease within six months before this survey. No relation was seen between blood type and immunoglobulin positivity. Seropositivity prevalence in low risk and high-risk populations were estimated 8.0 (95% CI: 1.0-16.8) and 5.2(95% CI: 1.2-9.8) respectively. The immunoglobulin test for SARS-COV-2 revealed that 64 (64/492, 13%) and 37 (37/492, 7.52%) subjects had IgG and IgM antibodies against the virus. 14 (14/169, 8.28%) individuals who had IgM were frontline health workers, this is while 23 (14/323, 7.12%) were non front lineConclusion: The findings of this study imply that seropositivity was lower in non-frontline health care staff. Furthermore, there was no association between blood type and seropositivity. Therefore, the knowledge of antibody status may help into overcome fears in clinical staff, and also more attention is need for interpreting the levels of anti-SARS-CoV-2 antibodies to make a clinical diagnosis of COVID-19, since the time of expose and time of test is an important point which should be considered in the issue.
Keywords: SARS-COV-2, Seroprevalence, antibodies, COVID-19
First Name
Last Name
Email Address
Security code

Abstract View: 231

Your browser does not support the canvas element.

PDF Download: 172

Your browser does not support the canvas element.